Viral subversion mechanisms in chronic kidney disease pathogenesis

Clinical Journal of the American Society of Nephrology

Volumn 2, Issue SUPPL. 1, 2007, Pages

  Bruggeman, Leslie A ^a  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS ANTIGEN; VIRUS DNA;

ANIMAL; CELLULAR IMMUNITY; CHRONIC DISEASE; GENETICS; HUMAN; IMMUNOLOGY; INNATE IMMUNITY; KIDNEY; KIDNEY DISEASE; MOLECULAR EVOLUTION; MUTATION; PATHOGENICITY; PATHOLOGY; REVIEW; SYMBIOSIS; VIROLOGY; VIRUS; VIRUS REPLICATION;

ANIMALS; ANTIGENS, VIRAL; CHRONIC DISEASE; DNA, VIRAL; EVOLUTION, MOLECULAR; HUMANS; IMMUNITY, CELLULAR; IMMUNITY, NATURAL; KIDNEY; KIDNEY DISEASES; MUTATION; SYMBIOSIS; VIRUS REPLICATION; VIRUSES;

EID: 34748887081     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.04311206     Document Type: Article

References (57)

1. Albrecht T, Fons M, Boldogn I, Rabson AS: Mechanisms of viral pathogenesis: Effects on cell. In: Medical Microbiology, 4th Ed., edited by Baron S, Galveston, The University of Texas Medical Branch, 1996
2. Heegaard ED, Brown KE: Human parvovirus B19. Clin Microbiol Rev 15: 485-505, 2002
3. Yaegashi N, Niinuma T, Chisaka H, Uehara S, Moffatt S, Tada K, Iwabuchi M, Matsunaga Y, Nakayama M, Yutani C, Osamura Y, Hirayama E, Okamura K, Sugamura K, Yajima A: Parvovirus B19 infection induces apoptosis of erythroid cells in vitro and in vivo. J Infect 39: 68-76, 1999
4. Alcami A: Viral mimicry of cytokines, chemokines and their receptors. Nat Rev Immunol 3: 36-50, 2003
5. Murphy PM: Viral exploitation and subversion of the immune system through chemokine mimicry. Nat Immunol 2: 116-122, 2001
6. Mocarski ES Jr: Immune escape and exploitation strategies of cytomegaloviruses: Impact on and imitation of the major histocompatibility system. Cell Microbiol 6: 707-717, 2004
7. Gale M Jr, Foy EM: Evasion of intracellular host defence by hepatitis C virus. Nature 436: 939-945, 2005
8. Lloyd AR, Jagger E, Post JJ, Crooks LA, Rawlinson WD, Hahn YS, Ffrench RA: Host and viral factors in the immunopathogenesis of primary hepatitis C virus infection. Immunol Cell Biol 85: 24-32, 2007
9. Sodhi A, Montaner S, Gutkind JS: Viral hijacking of G-protein-coupled-receptor signalling networks. Nat Rev Mol Cell Biol 5: 998-1012, 2004
10. Frankel AD, Young JA: HIV-1: Fifteen proteins and an RNA. Annu Rev Biochem 67: 1-25, 1998
11. Herman ES, Klotman PE: HIV-associated nephropathy: Epidemiology, pathogenesis, and treatment. Semin Nephrol 23: 200-208, 2003
12. Kimmel PL: HIV-associated nephropathy: Virologic issues related to renal sclerosis. Nephrol Dial Transplant 18[Suppl 6]: vi59-vi63, 2003
13. Husain M, Gusella GL, Klotman ME, Gelman IH, Ross MD, Schwartz EJ, Cara A, Klotman PE: HIV-1 Nef induces proliferation and anchorage-independent growth in podocytes. J Am Soc Nephrol 13: 1806-1815, 2002
14. Schwartz EJ, Cara A, Snoeck H, Ross MD, Sunamoto M, Reiser J, Mundel P, Klotman PE: Human immunodeficiency virus-1 induces loss of contact inhibition in podocytes. J Am Soc Nephrol 12: 1677-1684, 2001
15. He JC, Husain M, Sunamoto M, D'Agati VD, Klotman ME, Iyengar R, Klotman PE: Nef stimulates proliferation of glomerular podocytes through activation of Src-dependent Stat3 and MAPK1,2 pathways. J Clin Invest 114: 643-651, 2004
16. Husain M, D'Agati VD, He JC, Klotman ME, Klotman PE: HIV-1 Nef induces dedifferentiation of podocytes in vivo: A characteristic feature of HIVAN. AIDS 19: 1975-1980, 2005
17. Sunamoto M, Husain M, He JC, Schwartz EJ, Klotman PE: Critical role for Nef in HIV-1-induced podocyte dedifferentiation. Kidney Int 64: 1695-1701, 2003
18. Hanna Z, Kay DG, Rebai N, Guimond A, Jothy S, Jolicoeur P: Nef harbors a major determinant of pathogenicity for an AIDS-like disease induced by HIV-1 in transgenic mice. Cell 95: 163-175, 1998
19. Hanna Z, Kay DG, Cool M, Jothy S, Rebai N, Jolicoeur P: Transgenic mice expressing human immunodeficiency virus type 1 in immune cells develop a severe AIDS-like disease. J Virol 72: 121-132, 1998
20. Hanna Z, Weng X, Kay DG, Poudrier J, Lowell C, Jolicoeur P: The pathogenicity of human immunodeficiency virus (HW) type 1 Nef in CD4C/ HIV transgenic mice is abolished by mutation of its SH3-binding domain, and disease development is delayed in the absence of Hck. J Virol 75: 9378-9392, 2001
21. Hanna Z, Priceputu E, Kay DG, Poudrier J, Chrobak P, Jolicoeur P: In vivo mutational analysis of the N-terminal region of HIV-1 Nef reveals critical motifs for the development of an AIDS-like disease in CD4C/HW transgenic mice. Virology 327: 273-286, 2004
22. Zuo Y, Matsusaka T, Zhong J, Ma J, Ma LJ, Hanna Z, Jolicoeur P, Fogo AB, Ichikawa I: HIV-1 genes vpr and nef synergistically damage podocytes, leading to glomerulosclerosis. J Am Soc Nephrol 17: 2832-2843, 2006
23. Dickie P, Roberts A, Uwiera R, Witmer J, Sharma K, Kopp JB: Focal glomerulosclerosis in proviral and c-fms transgenic mice links Vpr expression to HIV-associated nephropathy. Virology 322: 69-81, 2004
24. Kajiyama W, Kopp JB, Marinos NJ, Klotman PE, Dickie P: Glomerulosclerosis and viral gene expression in HIV-transgenic mice: role of nef. Kidney Int 58: 1148-1159, 2000
25. Ray PE, Liu XH, Robinson LR, Reid W, Xu L, Owens JW, Jones OD, Denaro F, Davis HG, Bryant JL: A novel HIV-1 transgenic rat model of childhood HW-1-associated nephropathy. Kidney Int 63: 2242-2253, 2003
26. Barisoni L, Kopp JB: Modulation of podocyte phenotype in collapsing glomerulopathies. Microsc Res Tech 57: 254-262, 2002
27. Santoro MG, Rossi A, Amici C: NF-kappaB and virus infection: Who controls whom. EMBO J 22: 2552-2560, 2003
28. Bowie AG, Zhan J, Marshall WL: Viral appropriation of apoptotic and NF-kappaB signaling pathways. J Cell Biochem 91: 1099-1108, 2004
29. Hayden MS, Ghosh S: Signaling to NF-kappaB. Genes Dev 18: 2195-2224, 2004
30. DeLuca C, Petropoulos L, Zmeureanu D, Hiscott J: Nuclear IkappaBbeta maintains persistent NF-kappaB activation in HIV-1-infected myeloid cells. J Biol Chem 274: 13010-13016, 1999
31. McElhinny JA, MacMorran WS, Bren GD, Ten RM, Israel A, Paya CV: Regulation of I kappa B alpha and p105 in monocytes and macrophages persistently infected with human immunodeficiency virus. J Virol 69: 1500-1509, 1995
32. Martinka S, Bruggeman LA: Persistent NF-kappaB activation in renal epithelial cells in mouse model of HIV-associated nephropathy. Am J Physiol Renal Physiol 290: F657-F665, 2005
33. Ross MJ, Martinka S, D'Agati VD, Bruggeman LA: NF-kappaB regulates Fas-mediated apoptosis in HIV-associated nephropathy. J Am Soc Nephrol 16: 2403-2411, 2005
34. Nelson PJ, Sunamoto M, Husain M, Gelman IH: HIV-1 expression induces cyclin D1 expression and pRb phosphorylation in infected podocytes: Cell-cycle mechanisms contributing to the proliferative phenotype in HIV-associated nephropathy. BMC Microbiol 2: 26, 2002
35. Albaqumi M, Soos TJ, Barisoni L, Nelson PJ: Collapsing glomerulopathy. J Am Soc Nephrol 17: 2854-2863, 2006
36. Nelson PJ, D'Agati VD, Gries JM, Suarez JR, Gelman IH: Amelioration of nephropathy in mice expressing HIV-1 genes by the cyclin-dependent kinase inhibitor flavopiridol. J Antimicrob Chemother 51: 921-929, 2003
37. Gherardi D, D'Agati V, Chu TH, Barnett A, Gianella-Borradori A, Gelman IH, Nelson PJ: Reversal of collapsing glomerulopathy in mice with the cyclin-dependent kinase inhibitor CYC202. J Am Soc Nephrol 15: 1212-1222, 2004
38. Felsani A, Mileo AM, Paggi MG: Retinoblastoma family proteins as key targets of the small DNA virus oncoproteins. Oncogene 25: 5277-5285, 2006
39. Reploeg MD, Storch GA, Clifford DB: Bk virus: A clinical review. Clin Infect Dis 33: 191-202, 2001
40. Fioriti D, Videtta M, Mischitelli M, Degener AM, Russo G, Giordano A, Pietropaolo V: The human polyomavirus BK: Potential role in cancer. J Cell Physiol 204: 402-406, 2005
41. Tognon M, Corallini A, Martini F, Negrini M, Barbanti-Brodano G: Oncogenic transformation by BK virus and association with human tumors. Oncogene 22: 5192-5200, 2003
42. Barbanti-Brodano G, Sabbioni S, Martini F, Negrini M, Corallini A, Tognon M: BK virus, JC virus and Simian Virus 40 infection in humans, and association with human tumors. Adv Exp Med Biol 577: 1319-341, 2006
43. Gorrill T, Feliciano M, Mukerjee R, Sawaya BE, Khalili K, White MK: Activation of early gene transcription in polyomavirus BK by human immunodeficiency virus type 1 Tat. J Gen Virol 87: 1557-1566, 2006
44. Li RM, Mannon RB, Kleiner D, Tsokos M, Bynum M, Kirk AD, Kopp JB: BK virus and SV40 co-infection in polyomavirus nephropathy. Transplantation 74: 1497-1504, 2002
45. Peters CJ: Marburg and Ebola: Arming ourselves against the deadly filoviruses. N Engl J Med 352: 2571-2573, 2005
46. Heeney JL, Dalgleish AG, Weiss RA: Origins of HIV and the evolution of resistance to AIDS. Science 313: 462-466, 2006
47. Brander C, Walker BD: Gradual adaptation of HW to human host populations: Good or bad news? Nat Med 9: 1359-1362, 2003
48. Keele BF, Van Heuverswyn F, Li Y, Bailes E, Takehisa J, Santiago ML, Bibollet-Ruche F, Chen Y, Wain LV, Liegeois F, Loul S, Ngole EM, Bienvenue Y, Delaporte E, Brookfield JF, Sharp PM, Shaw GM, Peeters M, Hahn BH: Chimpanzee reservoirs of pandemic and nonpandemic HIV-1. Science 313: 523-526, 2006
49. Schindler M, Munch J, Kutsch O, Li H, Santiago ML, Bibollet-Ruche F, Muller-Trutwin MC, Novembre FJ, Peeters M, Courgnaud V, Bailes E, Roques P, Sodora DL, Silvestri G, Sharp PM, Hahn BH, Kirchhoff F: Nef-mediated suppression of T cell activation was lost in a lentiviral lineage that gave rise to HIV-1. Cell 125: 1055-1067, 2006
50. Centers for Disease Control: Summary of notifiable disease - United States, 2004. MMWR Weekly Report 53: 6-39, 2006
51. Helantera I, Koskinen P, Tornroth T, Loginov R, Gronhagen-Riska C, Lautenschlager I: The impact of cytomegalovirus infections and acute rejection episodes on the development of vascular changes in 6-month protocol biopsy specimens of cadaveric kidney allograft recipients. Transplantation 75: 1858-1864, 2003
52. Helantera I, Koskinen P, Finne P, Loginov R, Kyllonen L, Salmela K, Gronhagen-Riska C, Lautenschlager I: Persistent cytomegalovirus infection in kidney allografts is associated with inferior graft function and survival. Transpl Int 19: 893-900, 2006
53. Young NS, Brown KE: Parvovirus B19. N Engl J Med 350: 586-597, 2004
54. Azzi A, Cesaro S, Laszlo D, Zakrzewska K, Ciappi S, De SR, Fanci R, Pesavento G, Calore E, Bosi A: Human polyomavirus BK (BKV) load and haemorrhagic cystitis in bone marrow transplantation patients. J Clin Virol 14: 79-86, 1999
55. Cavallo R, Merlino C, Re D, Bollero C, Bergallo M, Lembo D, Musso T, Leonardi G, Segoloni GP, Ponzi AN: B19 virus infection in renal transplant recipients. J Clin Virol 26: 361-368, 2003
56. Hummel M, Abecassis MM: A model for reactivation of CMV from latency. J Clin Virol 25[Suppl 2]: S123-S136, 2002
57. Moffatt S, Tanaka N, Tada K, Nose M, Nakamura M, Muraoka O, Hirano T, Sugamura K: A cytotoxic nonstructural protein, NS1, of human parvovirus B19 induces activation of interleukin-6 gene expression. J Virol 70: 8485-8491, 1996